AORT: Artivion, Inc. Stock

by  •  • Comments Off on AORT: Artivion, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 1,015.15
Enterprise Value ($M) 1,276.04
Book Value ($M) 276.20
Book Value / Share 6.47
Price / Book 3.68
NCAV ($M) -222.82
NCAV / Share -5.22
Price / NCAV -4.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.05

Liquidity (mrq)
Quick Ratio 3.15
Current Ratio 4.34

Balance Sheet (mrq) ($M)
Current Assets 290.08
Assets 789.10
Liabilities 512.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 388.54
Operating Income 30.85
Net Income -13.36
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 22.24
Cash from Investing -28.19
Cash from Financing 2.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-08 13G/A BlackRock, Inc. 15.60 0.00
11-08 13G/A Wellington Management Group Llp 3.95 -32.66

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPORT PURSUANT
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 o TRANSITION REPORT PURSUANT TO S
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 o TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-24 54,033 244,706 22.08
2025-04-23 138,447 409,390 33.82
2025-04-22 78,329 250,089 31.32
2025-04-21 72,283 250,054 28.91

(click for more detail)

Similar Companies
ALUR – Allurion Technologies Inc. AVNS – Avanos Medical, Inc.
BAX – Baxter International Inc.


Financial data and stock pages provided by
Fintel.io